Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
455 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2023-12-13 (ottawasun.com)
ACRO Announces 2024 Officers and New Members
WASHINGTON — ACRO today announced that its Board of Directors has elected Peyton Howell, Chief Operating & Growth Officer at Parexel, as Chair of the...
Read more
2023-01-29 (biospectrumasia.com)
Parexel CEO to chair Association of CROs
Parexel International chairman and CEO, Mr Josef von Rickenbach, is the 2013 chairman of the Association of Clinical Research Organizations (ACRO)
Read more
2022-06-25 (parexel.com)
Corporate Responsibility | Parexel International Corporation
The Investor Relations website contains information about Parexel International Corporation's business for stockholders, potential investors, and financial analysts.
Read more
2022-06-14 (prnewswire.com)
Riverside Partners' Portfolio Company, Syner-G BioPharma Group, Appoints Ron Kraus as CEO
/PRNewswire/ -- Riverside Partners, a Boston based private equity firm, announced today that its portfolio company, Syner-G BioPharma Group ("Syner-G" or the...
Read more
2020-09-22 (outsourcing-pharma.com)
Parexel, Pfizer extend drug development partnership
The drug discovery and pharma companies have extended their agreement to collaborate on development of new treatments for a range of therapeutic areas.
Read more
2018-03-05 (parexel.com)
Parexel Appoints Jamie Macdonald as Chief Executive ...
05-03-2018 · Company Co-founder Josef von Rickenbach to retire after 35 years of leadership; serve as Chairman of the Board . BOSTON, March5, 2018– PAREXEL International Corporation, the world’ s leading innovator of biopharmaceutical services, today
Read more